Related Experiment Video
Updated: Apr 21, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
[Neonatal screening and the right to know: ethical considerations]
1Responsabile dell'Unità di Bioetica, Presidenza, Istituto Superiore di Sanità
Insights
Newborn screening using tandem mass spectrometry offers extensive metabolic data. However, ethical considerations arise regarding parental rights to know results not covered by national screening programs, especially when it may not benefit the child.
Area of Science:
- Biochemistry
- Medical Ethics
- Neonatal Care
Context:
- Tandem mass spectrometry (TMS) is a powerful analytical technique for metabolite profiling.
- Neonatal screening programs aim to detect congenital metabolic disorders early.
- International variations exist in the scope of disorders included in newborn screening.
Purpose:
- To explore the ethical implications of providing comprehensive TMS data beyond established national screening protocols.
- To examine the concept of parental "right to know" in the context of neonatal screening.
- To discuss the potential benefits and harms of disclosing incidental or non-standardized findings.
Summary:
- Tandem mass spectrometry (TMS) generates extensive metabolite data for neonatal screening of congenital metabolic disorders.
- Screening program variations across regions create an ethical dilemma regarding the "right to know" for parents.
- Ethical considerations include the non-absolute nature of the right to know, parental judgment, and prioritizing the patient's best interest.
Impact:
- Informs ethical guidelines for neonatal screening programs and genetic testing.
- Promotes discussion on data sharing and parental consent in healthcare.
- Highlights the importance of patient welfare over absolute information disclosure.
Abstract:
Tandem mass spectrometry provides information on numerous metabolites and is widely used for neonatal screening of congenital metabolic disorders. The list of disorders covered by screening programmes in different nations and regions varies, leading to the dilemma of whether parents have an absolute "right to know" information that can be provided by technology but that is not included in the programme implemented by one's country/region. The article discusses some ethical points to consider: the right to know is not absolute, parents are not always the best judges, and it may be in the patient's interest not to provide some of the information.
Related Concept Videos
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Issues
Ethical Concerns in Healthcare:
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

